Multiple esophageal submucosal hematomas
- Preventing TIAs: Ticlopidine is more effective than aspirin. // Geriatrics;Mar94, Vol. 49 Issue 3, p64
Presents an abstract on the article `Efficacy of ticlopidine and aspirin for prevention of reversible cerebrovascular ischemic events,' by A.Bellevance. Comparison between ticlopidine and aspirin recipients; Reduction of risk of reversible ischemic events.
- Randomized trial of prophylactic daily aspirin in British male doctors. Peto, R.; Gray, R.; Collins, R.; Wheatley, K.; Hennekens, C.; Jamrozik, K.; Warlow, C.; Hafner, B.; Thompson, E.; Norton, S.; Gilliland, J.; Doll, Richard // British Medical Journal (Clinical Research Edition);1/30/1988, Vol. 296 Issue 6618, p313
Presents the results of a randomized trial on the prophylactic daily aspirin among males in Great Britain. Analysis on the efficacy of aspirin in reducing stroke, myocardial infarction and other vascular conditions; Significance of migraine and musculoskeletal pain in the control and treated...
- Aspirin and Heparin in Acute Ischaemic Stroke in Older Patients. Gubitz, G.J.; Sandercock, P.A.G. // Drugs & Aging;1999, Vol. 15 Issue 1, p29
Over four-fifths of all strokes are due to thrombotic or embolic occlusion of cerebral arteries. There is a strong rationale for considering antithrombotic therapy for the treatment of patients with acute ischaemic stroke. Antiplatelet therapy with 150 to 300mg of aspirin (acetylsalicylic acid)...
- Ticlopidine vs. aspirin in the prevention of stroke. // American Family Physician;7/1/1994, Vol. 50 Issue 1, p178
Reviews the efficacy of ticlopidine versus aspirin in the prevention of stroke. Antiplatelet properties of ticlopidine; Other physiological effects; Establishment of the efficacy of ticlopidine; Aspirin's reducing effect on risks of ischemic stroke; Side effects.
- Aggrenox Receives Approval For TIA Patients. Cerrato, Paul L. // RN;Mar2000, Vol. 63 Issue 3, p96
Reports that a unique combination of dipyridamole and aspirin called Aggrenox has received United States government clearance as an anti-stroke agent. Effectiveness for patients suffering from transient ischemic attacks.
- Stroke prevention and acute intervention: Review of recent advances. Brockington, Carolyn D. // Formulary;Apr2000, Vol. 35 Issue 4, p328
Focuses on accepted and notable therapies for the prevention and acute treatment of stroke, with a particular emphasis on pharmacologic interventions. Consideration of aspirin as the first-line antiplatelet agent to prevent stroke; Treatment of acute stroke by thrombolysis. INSETS: Stroke...
- Aspirin. // Reactions Weekly;5/8/2010, Issue 1300, p9
The article presents the case of a 68-year-old woman who experienced painless haematemesis and subsequent retrosternal pain radiating to the epigastrum while receiving aspirin for cerebrovascular disease prevention.
- Adding vitamin E to aspirin can further reduce the risk of stroke by 25%. // Modern Medicine;Nov94, Vol. 62 Issue 11, p14
Reports that the addition of vitamin E to aspirin can reduce the risk of stroke among patients who have experienced a transient attack (TIA), according to Manfred Steiner, professor of medicine and director of the division of hematology at Brown University in Providence, Rhode Island. ...
- Flap over aspirin dosage for patients with cerebrovascular disease. // Modern Medicine;Aug96, Vol. 64 Issue 8, p60
Presents abstracts of the research, `Aspirin in Ischemic Cerebrovascular Disease: How Strong is the Case for a Different Dosing Regiment?,' by C. Patrono and G.J. Roth, and the editorials, `The Optional Dose of Aspirin to Prevent Stroke,' by R.G. Hart and M.J.G. Harrison, and `Aspirin Dose in...